In fight over Medicare payments, the hospital lobby shows its strength
In the battle to control health care costs, hospitals are deploying their political power to protect their bottom lines.
Feb 15, 2024
0
0
In the battle to control health care costs, hospitals are deploying their political power to protect their bottom lines.
Feb 15, 2024
0
0
Two senior senators—a Republican and a Democrat—unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs ...
Jul 23, 2019
0
0
The controversial practice has been standard in many teaching hospitals for decades, its safety and ethics largely unquestioned and its existence unknown to those most affected: people undergoing surgery.
Jul 28, 2017
1
2
A group advising the Food and Drug Administration on medical issues abruptly dropped four experts from a panel on prescription painkillers after concerns emerged about apparent ties to the pharmaceutical industry.
Jul 7, 2016
0
3
The makers of a breakthrough hepatitis drug put profits before patients in pricing the $1,000 pill that's become a symbol of the excessive cost of medications, Senate investigators said Tuesday.
Dec 1, 2015
1
0
Anti-addiction activists are calling on a Senate committee to release findings from a 3-year-old investigation into links between painkiller manufacturers and nonprofit medical groups.
Sep 16, 2015
0
9
(HealthDay)—The U.S. House Ways and Means Committee and the U.S. Senate Finance Committee have passed their versions of the bill to repeal Medicare's failed sustainable growth rate (SGR) formula, according to a report from ...
Dec 16, 2013
0
0
Lawmakers leave town at the end of this week with a lengthy to-do list, several health programs expiring Sept. 30 and very few work days left.
Jul 27, 2023
0
1
The Biden administration on Wednesday proposed a ban on misleading ads for Medicare Advantage plans that have targeted older Americans and, in some cases, convinced them to sign up for plans that don't cover their doctors ...
Dec 15, 2022
0
2
Basing new drug launch prices on historical domestic data could limit manufacturers' power to set extremely high launch prices and could reduce Medicare spending on new drugs by up to 30%, according to a new white paper released ...
Sep 23, 2021
0
13